BioImagene Gets $26M In Series D Funding
Cupertino-based BioImagene, a developer of digital pathology products used in cancer diagnostics and for preclinical research, said Tuesday that the firm has raised $26M in a Series D funding round. The round was led by Burrill & Company. Other investors in the round included Ascension Health Ventures, National Healthcare Services, Artiman Ventures and ICCP Ventures. BioImagene's products are used for digital pathology.
posted on Wednesday, August 20, 2008 (Link to more information)
Related companies:
BioImagene
Related stories:
> BioImagene Adds Siemens As Investor
> Rigetti Computing Gets $64M For Quantum Computing
> GageIn Gets Series A
> Virobay Gets $8M In Additional Series B
> Striim Adds $10M To Series B Funding
silicontap.com Home